Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05865470Phase 1Recruiting
Phase 1, randomised trial of dronabinol in pain (5 arms), sponsored by University of California, Los Angeles. Primary endpoints: Subject-rated drug effects at 6 hours, Analgesia as measured using the Cold Pressor Test at 6 hours and 2 more. Started Apr 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05865470.